Evaluation of indoleamine 2,3-dioxygenase expression and kynurenine pathway metabolites levels in serum samples of diabetic retinopathy patients

Archives of Physiology and Biochemistry

Volumn 117, Issue 5, 2011, Pages 254-258

  Munipally, Praveen Kumar ^a   Agraharm, Satish G ^b   Valavala, Vijay Kumar ^a   Gundae, Sridhar ^a   Turlapati, Naga Raju ^a  

^a OSMANIA UNIVERSITY   (India)

^b Vitreo Retinal Institute   (India)

Author keywords

3 hydroxy kynurenine; Diabetic retinopathy; Indoleamine 2,3 dioxygenase; Kynurenic acid; Kynurenine; Tryptophan metabolites

Indexed keywords

3 HYDROXYKYNURENINE; 3-HYDROXYKYNURENINE; BIOLOGICAL MARKER; DRUG DERIVATIVE; INDOLEAMINE 2,3 DIOXYGENASE; KYNURENIC ACID; KYNURENINE; TRYPTOPHAN;

ARTICLE; BLOOD; CASE CONTROL STUDY; DIABETIC RETINOPATHY; FEMALE; GENE EXPRESSION; GENETICS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HOSPITALIZATION; HUMAN; INDIA; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; RETINA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIABETIC RETINOPATHY; FEMALE; GENE EXPRESSION; HUMANS; INDIA; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; KYNURENIC ACID; KYNURENINE; MALE; MIDDLE AGED; RETINA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEVERITY OF ILLNESS INDEX; TRYPTOPHAN;

EID: 82455171754     PISSN: 13813455     EISSN: 17444160     Source Type: Journal    
DOI: 10.3109/13813455.2011.623705     Document Type: Article

References (21)

1. Armstrong D, Abdella N, Salman A, Miller N, Rahman EA, Bojancyzk M. (1992). Relationship of lipid peroxides to diabetic complications. J. Diab Comp 6:116-22.
2. Buczko AJ, Pawlak D, Tankiewicz A. (2001). Possible involvement of kynurenines in the pathogenesis of cataract in diabetic patients. Med Sci Monitor 7:742-5. (Pubitemid 32691755)
3. Costantino G. (2009). New promises for manipulation of kynurenine pathway in cancer and neurological diseases. Expert Opin Ther Targets 13:247-58.
4. Cotlier E, Sharma YR, Zuckerman J, Pucklin J, Teasley B, Irvine J. (1981). Plasma tryptophan in humans with diabetic and senile cataracts. Exp Eye Res 33:247-52. (Pubitemid 11051241)
5. Engerman RL. (1989). Pathogenesis of diabetic retinopathy. Diabetes 38:1203-6. (Pubitemid 19247412)
6. Herve C, Beyne P, Jamault H, Delacoux E. (1996). Determination of tryptophan and its kynurenine pathway metabolites in human serum by high-performance liquid chromatography with simultaneous ultraviolet and fluorimetric detection. J Chromatogr B 675:157-61. (Pubitemid 26036980)
7. Holmes EW. (1988). Determination of serum kynurenine and hepatic tryptophan dioxygenase activity by high liquid chromatography. Anal Biochem 172:518-25.
8. Koch HR, Ohrloff C, Bours J, Riemann G, Dragomirescu V, Hockwin O. (1982). Separation of lens proteins in rats with tryptophan deficiency cataracts. Exp Eye Res 34:479-86. (Pubitemid 12152190)
9. Kowluru RA, Tang J, Kern TS. (2001). Abnormalities of retinal metabolism in diabetes and experimental galactosemia. VII. Effect of long-term administration of antioxidants on the development of retinopathy. Diabetes 50:1938-42. (Pubitemid 33641616)
10. Malina HZ, Martin XD. (1993). Indoleamine 2,3-dioxygenase in the aqueous humor, iris/ciliary body, and retina of the bovine eye. Graefes Arch clin Exp Ophthalmol 231:482-6. (Pubitemid 23264124)
11. Raju TN, Kanth VR, Reddy PUM. (2007). Influence of kynurenines in pathogenesis of cataract formation in tryptophan-deficient regimen in Wistar rats. Indian J Exp Biol 45:543-8.
12. Schwarcz R (2004). The kynurenine pathway of tryptophan degradation as a drug target. Curr opin Pharmacol, 4:12-17. (Pubitemid 38145832)
13. Srinivasan K. (2005). Plant foods in the management of diabetes mellitus: Spices as beneficial anti diabetic food adjuncts. Int J Food Sci Nutr 56:399-414. (Pubitemid 43135377)
14. Stitt AW. (2003). The role of advanced glycation in the pathogenesis of diabetic retinopathy. Exp Mol Pathol 75:95-108. (Pubitemid 36798117)
15. Takikawa O, Littlejohn TK, Truscott RJW. (2001). Indoleamine 2,3-dioxygenase in the human lens, the first enzyme in the synthesis of UV filters. Exp Eye Res 72:271-7. (Pubitemid 32977980)
16. Takikawa O, Truscott RJW, Fukao M, Miwa S. (2003). Age related nuclear cataract and indoleamine 2, 3-dioxygenase initiated tryptophan metabolism in the human lens. Adv Exp Med Biol 527:277-85. (Pubitemid 38197653)
17. Thomas SR, Stocker R. (1999). Redox reactions related to indoleamine 2,3-dioxygenase and tryptophan metabolism along the kynurenine pathway. Redox Rep 4:199-220. (Pubitemid 30088218)
18. Van Heyningen R. (1971). Fluorescent glucoside in the human lens. Nature 230:393-4.
19. Wegener A, Golubnitschaja O, Breipohl W, Schild HH, Vrensen GFJM. (2002). Effects of dietary deficiency of selective amino acids on the function of the cornea and lens in rats. Amino Acids 23:337-42.
20. Yiquan C, Gilles JG. (2009). Kynurenine pathway metabolites in humans: Disease and healthy states. Int J Trypto Res 2:1-19.
21. Zarnowski T, Rejdak R, Zielinska-Rzecka E, Zrenner E, Grieb P, Zagorski Z, Junemann A, Turski WA. (2007). Elevated concentrations of kynurenic acid, a tryptophan derivative in dense nuclear cataracts. Curr Eye Res 32:27-32.